Who approves clinical trials in India?
the CDSCO
The Drugs Controller General of India (DCGI) is an official of the CDSCO who is the final regulatory authority for the approval of clinical trials in the country.
Are clinical trials allowed in India?
Government regulation Since 2009 the Central Drugs Standard Control Organization has mandated that anyone conducting clinical research in India must preregister in the Clinical Trials Registry – India before enrolling any research participants. Various government agencies and laws regulate clinical trials.
How clinical trials are conducted in India?
Prerequisites of conducting a clinical trial in India Permission from the Drugs Controller General, India (DCGI). Approval from respective Ethics Committee where the study is planned. Mandatory registration on the ICMR maintained website www.ctri.in.
Is a Phase 4 clinical trial mandatory?
Phase IV studies may be required by regulatory authorities or may be undertaken by the sponsoring company for competitive (finding a new market for the drug) or other reasons (for example, the drug may not have been tested for interactions with other drugs, or on certain population groups such as pregnant women, who …
What is Inda in clinical research?
Investigational new drug application abbreviated as INDA is a mandatory requirement filed with the FDA in order to seek permission for administering a new drug under investigation to Human subjects after completion of the preclinical studies on it.
When clinical trials started in India?
The Indian government also started registration of clinical trials in 2007. Although it was not mandatory to register the trial at that time but, in 2009, it became compulsory to register trial on www.ctri.nic.in (Sanghavi, 2013).
What is Dcgi approval?
Drugs Controller General of India (DCGI) is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India.
What is CT 10 form?
hereby apply for grant of permission to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis. Address for correspondence: 4. Details of new drugs and investigational new drugs to be manufactured [As per Annexure].
What is a Phase 5 clinical trial?
Phase 5 Clinical Trial means a post-registration clinical trial that is not required as a condition to, or for the maintenance of, any Marketing Approval or Pricing and/or Reimbursement Approval for a Licensed Product. Phase 5 Clinical Trials are commonly referred to as “post-marketing clinical trials”.
What percentage of clinical trials are conducted in India?
At the end of 2010 India was conducting 7% of phase III and 3% of phase II trials globally. In 2019 India was hosting about 1% of the world’s clinical trials. There was perception in the research community that the media had usefully brought public scrutiny of the ethics and conduct of clinical trials.
Who regulates clinical trials in India?
Various government agencies and laws regulate clinical trials. The Drugs Controller General of India grants approval for clinical trials and is the top level authority which specifically oversees clinical trials. The Drugs Controller is a part of the Central Drugs Standard Control Organisation and answers to that organization.
Does the media influence public scrutiny of clinical trials in India?
In 2019 India was hosting about 1% of the world’s clinical trials. There was perception in the research community that the media had usefully brought public scrutiny of the ethics and conduct of clinical trials.
What happens when someone dies during a clinical trial in India?
It is also known that when people die during trials in India, the trial organization rarely pays compensation to the family of the deceased. The research industry has formulas for calculating how much money to pay when someone dies in a clinical trial.